RESUMEN
The etiology of molar incisor hypomineralization (MIH) is unclear. Our hypothesis was that certain antibiotics cause MIH. We examined 141 schoolchildren for MIH and, from their medical files, recorded the use of antibiotics under the age of 4 yrs. MIH was found in 16.3% of children. MIH was more common among those children who had taken, during the first year of life, amoxicillin (OR=2.06; 95% CI, 1.01-4.17) or the rarely prescribed erythromycin (OR=4.14; 95% CI, 1.05-16.4), compared with children who had not received treatment. Mouse E18 teeth were cultured for 10 days with/without amoxicillin at concentrations of 100 microg/mL-4 mg/mL. Amoxicillin increased enamel but not dentin thickness. An altered pattern of amelogenesis may have interfered with mineralization. We conclude that the early use of amoxicillin is among the causative factors of MIH.
Asunto(s)
Amelogénesis/efectos de los fármacos , Amoxicilina/efectos adversos , Antibacterianos/efectos adversos , Hipoplasia del Esmalte Dental/inducido químicamente , Calcificación de Dientes/efectos de los fármacos , Animales , Niño , Eritromicina/efectos adversos , Femenino , Humanos , Incisivo/patología , Masculino , Ratones , Ratones Endogámicos , Diente Molar/patología , Estudios RetrospectivosRESUMEN
Dioxins are ubiquitous environmental poisons that cause disturbances in developing organs, including the teeth. Exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) at the cap stage leads to reduced tooth size and deformation of cuspal morphology. Our hypothesis was that TCDD affects the expression of genes specific for tooth development, which leads to these aberrations. Mouse embryonic E14 tooth germs were cultured for 24 hrs with/without 1 microM TCDD. Analysis of total RNA on Affymetrix arrays showed that TCDD altered the expression of 31 known genes by a fold factor of at least 2. Genes implied in tooth development expressed only slight changes. Genes active at the cap stage were selected for quantitative PCR analysis. Of these, the most highly up-regulated were Follistatin and Runx2, while TGFbeta1 and p21 were the most down-regulated genes. Incomplete tooth morphogenesis caused by TCDD may thus result from modified expression of developmentally regulated genes.
Asunto(s)
Contaminantes Ambientales/toxicidad , Regulación del Desarrollo de la Expresión Génica/efectos de los fármacos , Odontogénesis/efectos de los fármacos , Dibenzodioxinas Policloradas/toxicidad , Germen Dentario/efectos de los fármacos , Animales , Hidrocarburo de Aril Hidroxilasas/biosíntesis , Subunidad alfa 1 del Factor de Unión al Sitio Principal/biosíntesis , Inhibidor p21 de las Quinasas Dependientes de la Ciclina/biosíntesis , Citocromo P-450 CYP1A1/biosíntesis , Citocromo P-450 CYP1B1 , Folistatina/biosíntesis , Perfilación de la Expresión Génica , Ratones , Ratones Endogámicos , Hibridación de Ácido Nucleico , Odontogénesis/genética , Técnicas de Cultivo de Órganos , Reacción en Cadena de la Polimerasa/métodos , Factor de Crecimiento Transformador beta1/biosíntesisRESUMEN
Exposure to environmental dioxins via mother's milk may be one causative factor of mineralization defects in children's teeth. A prerequisite for the completion of enamel mineralization is the removal of enamel matrix. To test the hypothesis that dioxins interfere with enamel maturation, we administered lactating Han/Wistar rats a single dose of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD; 50 or 1000 micro g/kg) on the day after delivery and analyzed tissue sections of the pup heads at post-natal days (Pn) 9 and 22. By Pn22, the first and second molars of the exposed pups, but not controls, showed retention of enamel matrix. Predentin was thicker than normal. Immunostaining for the aryl hydrocarbon/dioxin receptor (AhR) and cytochrome P4501A1 (CYP1A1) in ameloblasts and odontoblasts was reduced, suggesting that TCDD interferes with tooth mineralization via AhR. Extinction of AhR may lead to abolition of CYP1A1 expression as a sign of impaired dental cell function.
Asunto(s)
Esmalte Dental/efectos de los fármacos , Dentina/efectos de los fármacos , Contaminantes Ambientales/efectos adversos , Lactancia , Dibenzodioxinas Policloradas/efectos adversos , Calcificación de Dientes/efectos de los fármacos , Ameloblastos/efectos de los fármacos , Amelogénesis/efectos de los fármacos , Animales , Distribución de Chi-Cuadrado , Citocromo P-450 CYP1A1/análisis , Femenino , Leche , Odontoblastos/efectos de los fármacos , Ratas , Ratas Endogámicas , Ratas Wistar , Receptores de Hidrocarburo de Aril/análisisRESUMEN
The interference with tooth development by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) was studied in dioxin-resistant Han/Wistar rats. Lactating dams were given a single dose of 50 or 1000 microg TCDD/kg body wt 1 day after delivery and the pup heads were analyzed radiographically or histologically at postnatal days 9 and/or 22. Of 19 animals studied histologically, 10 lacked one or more third molars, which were at the bud stage at the start of the experiment. A higher proportion of pups exposed to the higher dose (9/13) lacked third molars than those exposed to the lower dose (1/6) (27/52 and 2/24 teeth missing, respectively). Missing upper third molars (19/38) were more frequent than were lower (10/38). The development of the third molars present was retarded. The root tips of the more advanced first and second molars were prematurely closed and root formation was arrested, but eruption was not affected. Dentinogenesis of the continuously erupting lower incisor teeth was preeruptively arrested because of pulpal cell death. All the teeth of the control rat pups developed normally. In contrast to the control pups, none of the 11 experimental pups examined radiographically (6 exposed to the higher dose and 5 to the lower) showed mineralization of their third molar cusps. The results show that the effects of TCDD on rat tooth development depend on not only the dose but also the tooth type and developmental stage. Inasmuch as early tooth development is under the control of inductive interactions between the epithelium and the mesenchyme, the interference by TCDD with tooth morphogenesis with the consequent arrest of development is likely to involve epithelial-mesenchymal signaling.
Asunto(s)
Contaminantes Ambientales/toxicidad , Lactancia , Diente Molar/crecimiento & desarrollo , Dibenzodioxinas Policloradas/toxicidad , Animales , Femenino , Incisivo/diagnóstico por imagen , Incisivo/crecimiento & desarrollo , Masculino , Diente Molar/diagnóstico por imagen , Diente Molar/patología , Dibenzodioxinas Policloradas/administración & dosificación , Radiografía , Ratas , Ratas Wistar , Anomalías Dentarias/inducido químicamente , Anomalías Dentarias/patologíaRESUMEN
Tenascin-C is a protein of the extracellular matrix which has been suggested to regulate organogenesis. We have analysed the expression of tenascin-C mRNA during mouse tooth development. We show that it is transiently expressed during epithelial budding in the condensed dental mesenchyme, and that it reappears later in the dental papilla mesenchyme where it persists in the dental pulp but is downregulated in odontoblasts. Probes corresponding to the domains A4, B, and D of the differentially spliced and domain 7 of the constant region of the FNIII-like domain show similar patterns of hybridization. Dental epithelium has been shown to induce tenascin-C in early dental mesenchyme, and we show that growth factors in the transforming growth factor beta (TGFbeta) and fibroblast growth factor (FGF) families can mimic this effect. FGF-4, -8 and TGFbeta-1 proteins were applied locally by beads on dissected dental mesenchyme, and tenascin-C expression was analysed after 24 h culture by reverse transcriptase-polymerase chain reaction (RT-PCR) in situ hybridization, and immunohistochemistry. FGF-4 and TGFbeta-1 stimulated tenascin-C expression in E12 dental mesenchymes. RT-PCR showed induction of several tenascin-C isoforms by both TGFbeta-1 and FGFs. We conclude that several splice forms are expressed during mouse tooth development, and that TGFbeta- and FGF-family growth factors may act as epithelial signals inducing tenascin expression in the dental mesenchyme.
Asunto(s)
Empalme Alternativo/efectos de los fármacos , Papila Dental/embriología , Papila Dental/metabolismo , Tenascina/biosíntesis , Tenascina/genética , Animales , Inducción Embrionaria , Epitelio/metabolismo , Factores de Crecimiento de Fibroblastos/farmacología , Factores de Crecimiento de Fibroblastos/fisiología , Regulación del Desarrollo de la Expresión Génica/efectos de los fármacos , Hibridación in Situ , Mesodermo/metabolismo , Ratones , Ratones Endogámicos C57BL , Ratones Endogámicos CBA , Isoformas de Proteínas , Proteínas Recombinantes/farmacología , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Estimulación Química , Tenascina/química , Factor de Crecimiento Transformador beta/farmacología , Factor de Crecimiento Transformador beta/fisiologíaRESUMEN
The further development of allosteric HIV-1 RT inhibitors in the urea analogue series of PETT (phenylethylthiazolylthiourea) derivatives is described here. The series includes derivatives with an ethyl linker (1-5) and racemic (6-16) and enantiomeric (17-20) cis-cyclopropane compounds. The antiviral activity was determined both at the RT level and in cell culture on both wild-type and mutant forms of HIV-1. Most compounds have anti-HIV-1 activity on the wt in the nanomolar range. Resistant HIV-1 was selected in vitro for some of the compounds, and the time for resistant HIV-1 to develop was longer for urea-PETT compounds than it was for reference compounds. Preliminary pharmacokinetics in rats showed that compound 18 is orally bioavailable and penetrates well into the brain. The three-dimensional structure of complexes between HIV-1 RT and two enantiomeric compounds (17 and 18) have been determined. The structures show similar binding in the NNI binding pocket. The propionylphenyl moieties of both inhibitors show perfect stacking to tyrosine residues 181 and 188. The cyclopropyl moiety of the (+)-enantiomer 18 exhibits optimal packing distances for the interactions with leucine residue 100 and valine residue 179.
Asunto(s)
Aminopiridinas/síntesis química , Fármacos Anti-VIH/síntesis química , VIH-1/enzimología , Inhibidores de la Transcriptasa Inversa/síntesis química , Urea/análogos & derivados , Administración Oral , Aminopiridinas/química , Aminopiridinas/farmacocinética , Aminopiridinas/farmacología , Animales , Fármacos Anti-VIH/química , Fármacos Anti-VIH/farmacología , Disponibilidad Biológica , Cristalografía por Rayos X , Farmacorresistencia Microbiana , Inyecciones Intravenosas , Masculino , Modelos Moleculares , Conformación Molecular , Ratas , Inhibidores de la Transcriptasa Inversa/química , Inhibidores de la Transcriptasa Inversa/farmacocinética , Inhibidores de la Transcriptasa Inversa/farmacología , Estereoisomerismo , Relación Estructura-Actividad , Urea/síntesis química , Urea/química , Urea/farmacocinética , Urea/farmacologíaRESUMEN
Matrix metalloproteinases (MMPs) have been implicated in tissue remodelling and in regulation of cell-matrix interactions during organ development. The activity of MMPs is regulated by members of the TIMP (tissue inhibitors of metalloproteinase) family. We analyzed by in situ hybridization the expression of gelatinase A (MMP-2) and gelatinase B (MMP-9) as well as Timp-1, -2 and -3 during different stages of mouse tooth development. Gene expression was generally found in mesenchymal tissues except for Timp-3, which also was found in dental epithelial cells. During early tooth development, gelatinase A and Timp-2 were widely expressed in the branchial arch, while gelatinase B and Timp-1 and Timp-3 expression showed clear association with epithelial morphogenesis and was restricted to the mesenchyme at the tip of the growing tooth bud. Gelatinase A and Timp-1 showed transient expression in secretory odontoblasts at the time of basement membrane degradation, while Timp-2 expression continued throughout the dental papilla. At the time of tooth eruption, Timp-3 was expressed in most dental epithelial cells except secretory ameloblasts, and gelatinase B was intensely expressed in osteoclasts in the jaw bone. The exact co-localization of gelatinase A and Timp-1 in secretory odontoblasts, and the correlation between gelatinase B and Timp-3 during bone resorption may indicate interaction of the proteins during degradation of the basement membrane and in the control of ECM turnover in connection with tooth eruption.
Asunto(s)
Gelatinasas/biosíntesis , Odontogénesis/fisiología , Inhibidores de Proteasas/metabolismo , Inhibidores Tisulares de Metaloproteinasas/biosíntesis , Germen Dentario/enzimología , Animales , Membrana Basal/enzimología , Colagenasas/biosíntesis , Matriz Extracelular/enzimología , Regulación Enzimológica de la Expresión Génica , Hibridación in Situ , Metaloproteinasa 2 de la Matriz , Metaloproteinasa 9 de la Matriz , Metaloendopeptidasas/biosíntesis , Ratones , Odontoblastos/enzimología , Osteoclastos/enzimología , Inhibidor Tisular de Metaloproteinasa-1/biosíntesis , Inhibidor Tisular de Metaloproteinasa-2/biosíntesis , Inhibidor Tisular de Metaloproteinasa-3/biosíntesisRESUMEN
Mutations in the laminin gamma2 gene cause junctional epidermolysis bullosa, and enamel hypoplasias are frequently seen in these patients. Laminin gamma2 is one of the three polypeptide chains forming the basement membrane glycoprotein laminin-5. We have localized the expression of the laminin gamma2 gene by in situ hybridization during mouse tooth development from early morphogenesis to completion of crown development. The expression was restricted to epithelial cells. During the early morphogenesis of the tooth germ, laminin gamma2 was expressed by the outer dental epithelium and by the stellate reticulum cells. No expression was detected in the cells of the inner dental epithelium giving rise to ameloblasts. The pre-ameloblasts remained negative during the early bell stage, but, interestingly, expression was very prominently upregulated as the cells differentiated into ameloblasts. This upregulation appeared to coincide with the start of enamel matrix secretion. The ameloblasts expressed laminin gamma2 intensely throughout the period of active enamel deposition. The expression continued at a lower level in the maturation-stage ameloblasts covering the enamel surface. Immunolocalization of laminin-5 with polyclonal antibodies indicated that the protein formed a continuous lining at the basal surfaces of the cells expressing the laminin gamma2 transcripts. We suggest that the role of laminin-5 during enamel formation may be to strengthen the anchorage of the ameloblasts to the enamel matrix, and that the pathogenesis of enamel hypoplasias in cases of laminin-5 mutations could be associated with detachment of the ameloblast cell layer from the enamel surface.
Asunto(s)
Ameloblastos/metabolismo , Amelogénesis , Moléculas de Adhesión Celular/biosíntesis , Regulación del Desarrollo de la Expresión Génica , Germen Dentario/metabolismo , Animales , Anticuerpos Monoclonales , Moléculas de Adhesión Celular/genética , Diferenciación Celular , Hipoplasia del Esmalte Dental/genética , Epidermólisis Ampollosa de la Unión/genética , Hibridación in Situ , Ratones , Fragmentos de Péptidos/biosíntesis , Conejos , Germen Dentario/citología , Germen Dentario/embriología , Regulación hacia Arriba , KalininaRESUMEN
The attachment of the marginal gingiva to the tooth surface is mediated by a thin nonkeratinized epithelium termed the junctional epithelium (JE). Ultrastructural studies have revealed that the attachment of the JE to the tooth surface occurs through hemidesmosomes (HD) and a basal lamina-like extracellular matrix termed the internal basal lamina (IBL). We have previously shown that neither type IV collagen nor prototypic laminin, two common components of basement membranes (BM), is present in the IBL between the epithelium and the tooth. In the present study, we show that laminin-5 is a major component of the IBL in both rodent and human tissues. By using in situ hybridization, we also show that the cells of the JE express the LAMC2 gene of laminin-5. In other parts of gingival epithelium, LAMC2 gene expression is less prominent. Our results indicate that the epithelium-tooth interface is a unique structure wherein epithelial cells are induced to secrete a basal lamina containing laminin-5 and no other presently known laminin isoform.
Asunto(s)
Membrana Basal/ultraestructura , Moléculas de Adhesión Celular/análisis , Inserción Epitelial/ultraestructura , Diente/ultraestructura , Animales , Membrana Basal/metabolismo , Adhesión Celular , Moléculas de Adhesión Celular/genética , Desmosomas/metabolismo , Desmosomas/ultraestructura , Inserción Epitelial/metabolismo , Células Epiteliales/metabolismo , Células Epiteliales/ultraestructura , Matriz Extracelular/metabolismo , Matriz Extracelular/ultraestructura , Técnica del Anticuerpo Fluorescente Directa , Regulación de la Expresión Génica , Encía/metabolismo , Encía/ultraestructura , Humanos , Técnicas para Inmunoenzimas , Hibridación in Situ , Ratones , Ratones Endogámicos , Microscopía Fluorescente , Ratas , Ratas Wistar , KalininaRESUMEN
A series of potent specific HIV-1 RT inhibitory compounds is described. The compounds are urea analogs of PETT (PhenylEthylThiazoleThiourea) derivatives and the series includes derivatives with an ethyl linker (1-6) and conformationally restricted analogs (7-13). The antiviral activity is determined both at the RT level and in cell culture on both native and mutant forms of HIV-1. Many compounds display activity in the nM range against wt-RT.
Asunto(s)
Fármacos Anti-VIH/síntesis química , Fármacos Anti-VIH/farmacología , VIH-1/efectos de los fármacos , Inhibidores de la Transcriptasa Inversa/síntesis química , Inhibidores de la Transcriptasa Inversa/farmacología , Tiazoles/farmacología , Triazoles/farmacología , Fármacos Anti-VIH/metabolismo , Proteínas Sanguíneas/metabolismo , Línea Celular , Humanos , Pruebas de Sensibilidad Microbiana , Unión Proteica , Inhibidores de la Transcriptasa Inversa/metabolismo , Relación Estructura-Actividad , Tiazoles/química , Tiazoles/metabolismo , Triazoles/química , Triazoles/metabolismoRESUMEN
The complete primary structure of the mouse laminin alpha4 chain was derived from cDNA clones. The translation product contains a 24-residue signal peptide preceding the mature alpha4 chain of 1,792 residues. Northern analysis on whole mouse embryos revealed that the expression was weak at day 7, but it later increased and peaked at day 15. In adult tissues the strongest expression was observed in lung and cardiac and skeletal muscles. Weak expression was also seen in other adult tissues such as brain, spleen, liver, kidney, and testis. By in situ hybridization of fetal and newborn tissues, expression of the laminin alpha4 chain was mainly localized to mesenchymal cells. Strong expression was seen in the villi and submucosa of the developing intestine, the mesenchymal stroma surrounding the branching lung epithelia, and the external root sheath of vibrissae follicles, as well as in cardiac and skeletal muscle fibers. In the developing kidney, intense but transient expression was associated with the differentiation of epithelial kidney tubules from the nephrogenic mesenchyme. Immunohistologic staining with affinity-purified IgG localized the laminin alpha4 chain primarily to lung septa, heart, and skeletal muscle, capillaries, and perineurium.
Asunto(s)
Regulación del Desarrollo de la Expresión Génica , Laminina/química , Secuencia de Aminoácidos , Animales , ADN Complementario , Técnicas para Inmunoenzimas , Hibridación in Situ , Laminina/genética , Laminina/metabolismo , Ratones , Datos de Secuencia MolecularRESUMEN
Phenylethylthiazolylthiourea (PETT) derivatives have been identified as a new series of non-nucleoside inhibitors of HIV-1 RT. Structure-activity relationship studies of this class of compounds resulted in the identification of N-[2-(2-pyridyl)ethyl]-N'-[2-(5-bromopyridyl)]-thiourea hydrochloride (trovirdine; LY300046.HCl) as a highly potent anti-HIV-1 agent. Trovirdine is currently in phase one clinical trials for potential use in the treatment of AIDS. Extension of these structure-activity relationship studies to identify additional compounds in this series with improved properties is ongoing. A part of this work is described here. Replacement of the two aromatic moieties of the PETT compounds by various substituted or unsubstituted heteroaromatic rings was investigated. In addition, the effects of multiple substitution in the phenyl ring were also studied. The antiviral activities were determined on wild-type and constructed mutants of HIV-1 RT and on wild-type HIV-1 and mutant viruses derived thereof, Ile100 and Cys181, in cell culture assays. Some selected compounds were determined on double-mutant viruses, HIV-1 (Ile 100/Asn103) and HIV-1 (Ile100/Cys181). A number of highly potent analogs were synthesized. These compounds displayed IC50's against wild-type RT between 0.6 and 5 nM. In cell culture, these agents inhibited wild-type HIV-1 with ED50's between 1 and 5 nM in MT-4 cells. In addition, these derivatives inhibited mutant HIV-1 RT (Ile 100) with IC50's between 20 and 50 nM and mutant HIV-1 RT (Cys 181) with IC50's between 4 and 10 nM, and in cell culture they inhibited mutant HIV-1 (Ile100) with ED50's between 9 and 100 nM and mutant HIV-1 (Cys181) with ED50's between 3 and 20 nM.
Asunto(s)
Fármacos Anti-VIH/farmacología , Transcriptasa Inversa del VIH/antagonistas & inhibidores , Sustancias Intercalantes/farmacología , Tiazoles/farmacología , Tiourea/análogos & derivados , Animales , Fármacos Anti-VIH/química , Células Cultivadas , Relación Estructura-Actividad , Tiazoles/química , Tiourea/química , Tiourea/farmacologíaRESUMEN
Tenascin is a large oligomeric glycoprotein of the extracellular matrix that is expressed prominently during embryonic development and wound healing. Previous studies on tenascin expression in wounds have used immunohistochemistry to describe the expression of tenascin in wounds. The present study used in situ hybridization to identify the cells expressing tenascin mRNA in healing wounds. The results demonstrate that the cells of the basal layer of epidermis, migrating over the healing wound, are expressing the mRNA for tenascin. Intense expression was seen during the first three days after wounding, but after seven days, after the epithelium had grown to cover the wound, no tenascin transcripts were seen in epithelial cells. The epithelial cells elsewhere in the skin were devoid of tenascin transcripts at all stages examined. Previously, prominent immunohistological staining for tenascin has been located in wounds below the migrating epithelial cells and it has been thought to be synthesized by stromal cells upon epithelial induction. Our findings in the present study indicate that tenascin is produced by epithelial cells, which apparently are induced to produce tenascin as they migrate after wounding.
Asunto(s)
ARN Mensajero/genética , Piel/metabolismo , Tenascina/genética , Animales , Movimiento Celular , Sondas de ADN , ADN Complementario , Epitelio/lesiones , Epitelio/metabolismo , Regulación de la Expresión Génica , Inmunohistoquímica , Hibridación in Situ , Datos de Secuencia Molecular , Reacción en Cadena de la Polimerasa , ARN Mensajero/análisis , Ratas , Ratas Sprague-Dawley , Piel/lesiones , Tenascina/análisis , Factores de Tiempo , Transcripción Genética/genética , Cicatrización de Heridas/genéticaRESUMEN
A new class of very potent and selective non-nucleoside inhibitors of HIV reverse transcriptase (RT) has recently been identified. The prototype compound trovirdine (LY 300046 HCl) and one analogue, MSC-127, have been studied with respect to inhibition of wild-type HIV-1 RT and RT with various mutations known to give rise to resistance to other non-nucleoside RT inhibitors, namely Leu100-->Ile (Ile100), Glu138-->Arg (Arg138), Tyr181-->Cys (Cys181) and Tyr188-->His (His188). The inhibition of HIV-1 RT by trovirdine and MSC-127 was reversible and template dependent. Trovirdine inhibited HIV-1 RT with an IC50 of 0.007 microM when employing heteropolymeric primer/template (oligo-DNA/ribosomal RNA) and dGTP as substrate. Enzyme kinetic studies showed that inhibition of RT by trovirdine was non-competitive with regard to deoxynucleoside triphosphates and uncompetitive with respect to varied primer/template under steady-state conditions. The amino acid changes Leu100, Tyr181 and Tyr188 gave rise to 25-, 147- and 12-fold decrease in inhibition by trovirdine. Enzyme-kinetic studies on trovirdine have been carried out using various RT mutants and compared to the properties of the earlier reported non-nucleoside RT inhibitors 9-Cl-TIBO, nevirapine and L-697,661.
Asunto(s)
Antivirales/farmacología , VIH-1/enzimología , Piridinas/farmacología , ADN Polimerasa Dirigida por ARN/efectos de los fármacos , Tiourea/análogos & derivados , Secuencia de Bases , Activación Enzimática , Transcriptasa Inversa del VIH , Cinética , Datos de Secuencia Molecular , Mutación , ADN Polimerasa Dirigida por ARN/genética , ADN Polimerasa Dirigida por ARN/metabolismo , Inhibidores de la Transcriptasa Inversa/farmacología , Tiourea/farmacologíaRESUMEN
The developmental regulation of various receptor forms may be a key-element in the local fine tuning of growth factor effects. The present study focuses on the tissue- and stage-specificity of the alternative splicing of EGF receptor transcripts in the rat incisor. In situ hybridization, as well as light- and electron-microscopic immunolocalization were performed with a set of tools which enable us to discriminate the full-length and secreted truncated forms of EGF receptor. Our data show that, apart from a transient expression in differentiating odontoblasts, EGF receptor expression was predominantly observed in the dental epithelium. In the crown, the expression of the full-length EGF receptor was maximal during preameloblast proliferation and differentiation, decreased in differentiated ameloblasts, and remained low throughout enamel secretion. On the other hand, maturation stage ameloblasts, which regulate the final mineralization of enamel, express high levels of the full-length EGF receptor. In contrast with ameloblasts, epithelial supra-ameloblastic cells, which are not directly involved in the deposition of enamel matrix, showed an alternating predominance of the secreted truncated form during the secretion stage, and the full-length form during the maturation stage. The presence of the secreted truncated EGF receptor form was supported by the electron microscopic detection of extracellular aggregates of immunoreactive EGF receptor. Finally, Northern-blotting of enamel organ samples confirmed the presence of transcripts corresponding to mRNAs of both EGF receptor forms. During root formation, a decreasing gradient of full-length EGF receptor form expression was observed from the apical loop to the disrupting zone in root epithelium. The secreted truncated EGF receptor form was essentially detected in epithelial cells of the disrupting zone of root epithelium. During crown formation, the secreted truncated EGF receptor form, which appears to be synthesized by epithelial supra-ameloblastic cells and secreted toward ameloblasts, may competitively bind EGF receptor ligands and modify activation of the full-length EGF receptor.
Asunto(s)
Envejecimiento/fisiología , Esmalte Dental/fisiología , Receptores ErbB/biosíntesis , Regulación de la Expresión Génica , Incisivo/metabolismo , Empalme Alternativo , Ameloblastos/citología , Ameloblastos/metabolismo , Animales , Anticuerpos , Northern Blotting , Receptores ErbB/análisis , Humanos , Inmunohistoquímica , Incisivo/citología , Incisivo/crecimiento & desarrollo , Masculino , Microscopía Inmunoelectrónica , Odontoblastos/citología , Odontoblastos/metabolismo , Sondas ARN , ARN Mensajero/análisis , ARN Mensajero/biosíntesis , Ratas , Ratas Sprague-DawleyRESUMEN
The existence of transient putative tooth anlagen in the prospective mouse upper diastema region has been documented previously in morphological studies. By in situ hybridization we investigated the expression patterns of the msx-1, msx-2, BMP-2 and BMP-4 genes, supposed to regulate early tooth development, in day 10-14 mouse embryonic upper diastema and molar regions, using 49 series of frontal sections. On the basis of comparison of the temporo-spatial expression patterns in both diastemal and molar tooth primordia we conclude that each of the four genes was expressed at least for some period simultaneously and at a comparable developmental stage in the transient and persisting dental primordia. BMP-2 and BMP-4 expression was downregulated in the diastemal dental primordia during their regression starting at day 13. The temporo-spatial pattern of BMPs expression may be associated with the disappearance of diastemal rudiments. Contrary to the molar anlage, we did not detect msx-2 gene expression in the diastemal dental rudiments after the stage of epithelial thickening. The deficiency of the msx-2 gene products may play a role in the growth retardation of diastemal dental primordia resulting in their subsequent involution.
Asunto(s)
Proteínas de Unión al ADN/biosíntesis , Diastema/embriología , Desarrollo Embrionario y Fetal , Expresión Génica , Proteínas de Homeodominio/biosíntesis , Diente Molar/embriología , Biosíntesis de Proteínas , Germen Dentario/fisiología , Factores de Transcripción , Animales , Proteínas Morfogenéticas Óseas , Femenino , Edad Gestacional , Sustancias de Crecimiento/biosíntesis , Factor de Transcripción MSX1 , Ratones , Ratones Endogámicos CBA , Ratones Endogámicos , Diente Molar/metabolismo , Embarazo , Germen Dentario/metabolismo , Transcripción GenéticaRESUMEN
Expression of 72 kDa and 92 kDa type IV collagenases and the metalloproteinase inhibitors TIMPs 1, 2, and 3 was studied by in situ hybridization in implanting mouse embryos of days 5.5 to 7.5. The 92 kDa type IV collagenase was strongly expressed in invading trophoblasts, signals above background not being observed in the embryonic proper or placental tissue. In contrast, signals above background were not seen for the 72 kDa enzyme in any cells of the implantation region, including trophoblasts and stromal cells of the decidual tissue. Only cells in the mucosal stroma outside the decidual region displayed some expression. TIMP-3 was intensily expressed in maternal cells in the area surrounding the invading embryonic tissue. No expression was observed for TIMP-1 or TIMP-2 in the embryo proper, trophoblasts, or the area of the uterine decidual reaction. Weak signals appeared for TIMP-1 only in the circular layer of myometrial smooth muscle and in some uterine stroma cells distant from the site of embryo implantation. The results suggest a central role for 92 kDa type IV collagenase and TIMP-3 in the extracellular proteolysis associated with implantation of the early embryo.
Asunto(s)
Colagenasas/biosíntesis , Decidua/enzimología , Implantación del Embrión , Metaloendopeptidasas/antagonistas & inhibidores , Biosíntesis de Proteínas , Trofoblastos/enzimología , Animales , Membrana Basal/metabolismo , Colagenasas/clasificación , Colagenasas/genética , Inducción Enzimática , Matriz Extracelular/metabolismo , Femenino , Glicoproteínas/análisis , Ratones , Ratones Endogámicos C57BL , Ratones Endogámicos CBA , Peso Molecular , Proteínas/análisis , Proteínas/genética , Inhibidor Tisular de Metaloproteinasa-2 , Inhibidor Tisular de Metaloproteinasa-3 , Inhibidores Tisulares de MetaloproteinasasRESUMEN
A novel murine plasma membrane protein has been identified in subpopulations of macrophages. It has an intracellular N-terminal domain, a transmembrane domain, and an extracellular region with a short spacer, an 89 Gly-Xaa-Yaa repeat-containing collagenous domain, and a C-terminal cysteine-rich domain. In situ hybridization and immunohistochemical staining have localized the protein to a subset of macrophages in the marginal zone of the spleen and the medullary cord of lymph nodes. No expression was observed in macrophages of liver or lung. Transfected COS cells synthesized a native trimeric plasma membrane protein that bound labeled bacteria and acetylated LDL, but not yeast or Ficoll. The results suggest that the novel protein is a macrophage-specific membrane receptor with a role in host defense, as it shows postnatal expression in macrophages, which are considered responsible for the binding of bacterial antigens and phagocytosis.